Lancet study finds no benefit for hydroxychloroquine in Covid-19 patients

Boston, May 22: Treatment for COVID-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for COVID-19 patients, according to a large observational study. The research, published in…